These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The potential of FimH as a novel therapeutic target for the treatment of Crohn's disease. Sivignon A; Bouckaert J; Bernard J; Gouin SG; Barnich N Expert Opin Ther Targets; 2017 Sep; 21(9):837-847. PubMed ID: 28762293 [TBL] [Abstract][Full Text] [Related]
30. The Short-Chain Fatty Acids Propionate and Butyrate Augment Adherent-Invasive Escherichia coli Virulence but Repress Inflammation in a Human Intestinal Enteroid Model of Infection. Pace F; Rudolph SE; Chen Y; Bao B; Kaplan DL; Watnick PI Microbiol Spectr; 2021 Oct; 9(2):e0136921. PubMed ID: 34612688 [TBL] [Abstract][Full Text] [Related]
31. Abnormal CEACAM6 expression in Crohn disease patients favors gut colonization and inflammation by adherent-invasive E. coli. Barnich N; Darfeuille-Michaud A Virulence; 2010; 1(4):281-2. PubMed ID: 21178454 [TBL] [Abstract][Full Text] [Related]
32. Lactoferrin prevents invasion and inflammatory response following E. coli strain LF82 infection in experimental model of Crohn's disease. Bertuccini L; Costanzo M; Iosi F; Tinari A; Terruzzi F; Stronati L; Aloi M; Cucchiara S; Superti F Dig Liver Dis; 2014 Jun; 46(6):496-504. PubMed ID: 24631031 [TBL] [Abstract][Full Text] [Related]
33. Escherichia coli bacteria associated with Crohn's disease persist within phagolysosomes. Bruder E; Espéli O Curr Opin Microbiol; 2022 Dec; 70():102206. PubMed ID: 36182819 [TBL] [Abstract][Full Text] [Related]
34. Escherichia coli-host macrophage interactions in the pathogenesis of inflammatory bowel disease. Tawfik A; Flanagan PK; Campbell BJ World J Gastroenterol; 2014 Jul; 20(27):8751-63. PubMed ID: 25083050 [TBL] [Abstract][Full Text] [Related]
35. Adaptation of adherent-invasive Sevrin G; Massier S; Chassaing B; Agus A; Delmas J; Denizot J; Billard E; Barnich N Gut Microbes; 2020 May; 11(3):364-380. PubMed ID: 29494278 [TBL] [Abstract][Full Text] [Related]
36. A Novel Strategy to Study the Invasive Capability of Adherent-Invasive Mayorgas A; Dotti I; Martínez-Picola M; Esteller M; Bonet-Rossinyol Q; Ricart E; Salas A; Martínez-Medina M Front Immunol; 2021; 12():646906. PubMed ID: 33854511 [TBL] [Abstract][Full Text] [Related]
37. Long-read sequencing to interrogate strain-level variation among adherent-invasive Escherichia coli isolated from human intestinal tissue. Wang J; Bleich RM; Zarmer S; Zhang S; Dogan B; Simpson KW; Arthur JC PLoS One; 2021; 16(10):e0259141. PubMed ID: 34710159 [TBL] [Abstract][Full Text] [Related]
38. Crohn's disease-associated AIEC inhibiting intestinal epithelial cell-derived exosomal let-7b expression regulates macrophage polarization to exacerbate intestinal fibrosis. Xu Y; Qian W; Huang L; Wen W; Li Y; Guo F; Zhu Z; Li Z; Gong J; Yu Z; Zhou Y; Lu N; Zhu W; Guo Z Gut Microbes; 2023; 15(1):2193115. PubMed ID: 36945126 [TBL] [Abstract][Full Text] [Related]
39. An adherent-invasive Escherichia coli-colonized mouse model to evaluate microbiota-targeting strategies in Crohn's disease. Sivignon A; Chervy M; Chevarin C; Ragot E; Billard E; Denizot J; Barnich N Dis Model Mech; 2022 Oct; 15(10):. PubMed ID: 36172858 [TBL] [Abstract][Full Text] [Related]
40. Ribonucleotide reductase NrdR as a novel regulator for motility and chemotaxis during adherent-invasive Escherichia coli infection. Dreux N; del Mar Cendra M; Massier S; Darfeuille-Michaud A; Barnich N; Torrents E Infect Immun; 2015 Apr; 83(4):1305-17. PubMed ID: 25605769 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]